Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110358752A reveals enzymatic route for high-purity Brivaracetam intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101074209A details a novel Cu-catalyzed route for (Z)-3-(bromomethylene)isoindolin-1-one. Discover cost-effective synthesis and scalable supply chain solutions.
Advanced process for Nebivolol intermediates using B-alkyl Suzuki cyclization. Enhances purity and supply chain reliability for cardiovascular API manufacturing.
Novel one-step synthesis of pyrazolo[4,3-c]quinoline derivatives using triflic acid. High yield, metal-free process for pharma intermediates.
Patent CN113072456A details a novel copper-catalyzed asymmetric difluoromethylation for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN113461589A details a novel one-step asymmetric Friedel-Crafts reaction yielding high-purity chiral indoleamines with significant cost reduction potential.
Patent CN103087028A details a robust Grignard-Suzuki route for Nebivolol intermediates, offering cost reduction and scalable chiral chroman manufacturing for global supply chains.
Novel patent CN115925616B offers high purity lercanidipine via green catalytic routes ensuring supply chain stability and reduced toxic reagent usage for global buyers
Patent CN102212060A details a novel aminolysis route for Lafutidine, eliminating dihydro impurities and offering significant cost reduction in pharmaceutical manufacturing.
Novel resolution method for high-purity chiral pyrazolo isoquinoline. Cost-effective scalable process for PARP inhibitor intermediates ensuring supply chain reliability.
Patent CN101792400A details a high-yield four-step route for Agomelatine, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN113149937A details a novel one-pot two-step synthesis of bio-based diamines. Discover cost reduction in polymer additive manufacturing and high-purity production capabilities.
Patent CN116947830A reveals metal-free visible light synthesis for coumarin heterocycles, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel copper-catalyzed method offers high yield and safety for pharmaceutical intermediates manufacturing supply chain ensuring reliable global sourcing and substantial cost efficiency.
Patent CN108368050A details improved crotonyl aminopyridine synthesis yielding high purity intermediates. This process reduces purification steps and enhances supply chain reliability for global pharmaceutical manufacturers seeking cost effective solutions.
Patent CN1931857A reveals a scalable permanganate oxidation route for Losartan 5-carboxylate (EXP-3174), offering high purity and eliminating chromatography for cost-effective API manufacturing.
Patent CN104529935A enables high-purity synthesis with reduced steps. Delivers significant cost reduction and supply chain reliability for global buyers.
Patent CN103073492A details a green Ru-catalyzed transfer hydrogenation for Montelukast intermediates, offering significant cost reduction and supply chain reliability.
Advanced preparation of cyclohexene carboxylates for neuraminidase inhibitors. Optimized route offers cost reduction and scalable manufacturing for API intermediates.
Patent CN103360458B details a novel Abiraterone synthesis route avoiding palladium. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.